RHUMBLINE ADVISERS

Position in OABIW — OmniAb, Inc.

CIK 1115418 BOSTON, MA

Position in OABIW

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

+$0 QoQ

Shares Held

171,957

+8.0% QoQ

Ownership

0.118%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 34% Shared 0% None 66%

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,404,298,250 across 329 Biotechnology names. OABIW ranks #328 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	396,380	$196,893,837
2	REGN	Regeneron Pharmaceuticals, Inc.	157,794	$98,390,870
3	MRNA	Moderna, Inc.	809,853	$56,714,005
4	ALNY	Alnylam Pharmaceuticals, Inc.	165,579	$49,844,246
5	INCY	Incyte Corp	428,533	$48,578,500
6	RVMD	Revolution Medicines, Inc.	226,008	$42,326,778
7	ROIV	Roivant Sciences Ltd.	1,178,789	$41,717,342
8	JAZZ	Jazz Pharmaceuticals plc	163,018	$39,282,447

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	—	171,957	+8.0%	Shares	Sole	2026-08-12
2026-03-31	—	159,235	-2.2%	Shares	Sole	2026-05-12
2025-12-31	—	162,773	+1.1%	Shares	Sole	2026-02-13
2025-09-30	—	160,936	+0.1%	Shares	Sole	2025-11-06
2025-06-30	—	160,728	+6.0%	Shares	Sole	2025-08-12
2025-03-31	—	151,565	-1.5%	Shares	Sole	2025-05-29
2024-12-31	—	153,812	-11.4%	Shares	Sole	2025-05-29
2024-09-30	—	173,641	+7.7%	Shares	Sole	2024-11-12
2024-06-30	—	161,185	-0.9%	Shares	Sole	2024-08-01
2024-03-31	—	162,577	+2.6%	Shares	Sole	2024-05-09
2023-12-31	—	158,520	+5.3%	Shares	Sole	2024-02-08
2023-09-30	—	150,564	-0.2%	Shares	Sole	2023-11-09
2023-06-30	—	150,823	+17.6%	Shares	Sole	2023-08-08
2023-03-31	—	128,289	+4.1%	Shares	Sole	2023-05-11
2022-12-31	—	123,280	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.